Effect of LEGALON SIL on Hepatitis C Virus Recurrence in Stable Liver Transplanted Patients

NCT01518933 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class

Stopped when a blind review highlighted that at least 43% of patients had a virological response

Conditions

Interventions

Sponsor

Rottapharm

Collaborators